CHAOJU EYE CARE (02219) Plans to Repurchase Up to HK$50 Million Worth of Shares

Stock News11-18

CHAOJU EYE CARE (02219) announced on November 17, 2025, that its board of directors has resolved to repurchase up to HK$50 million worth of the company's shares in the open market from time to time, starting November 17, 2025. This decision is based on the share repurchase mandate approved by shareholders at the annual general meeting held on June 6, 2025, and any subsequent renewals or amendments as applicable.

The company believes the share repurchase demonstrates confidence in its business outlook and prospects, which will ultimately benefit the company and create value for shareholders. Depending on market conditions, the board may increase the maximum repurchase amount under the mandate. If such an adjustment is made, the company will promptly announce it in compliance with listing rules.

The board confirms that the company has sufficient financial resources to execute the repurchase while maintaining a strong financial position.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment